Avoid common mistakes on your manuscript.
Introduction
Diabetes mellitus (DM) has been reported to increase the risk of fractures due to pathophysiological changes in the bone endocrinology, as well as disorders in glucose metabolism [1]. The prevalence of DM has continued to increase [2], and subsequently it increases the comorbidity burden higher.
In addition to the increasing prevalence of DM, the rates of gestational diabetes mellitus (GDM) have been increasing during previous decade [3]. Furthermore, as women whose pregnancies are complicated with GDM are in increased risk of developing the type 2 DM [4], it might also increase the risk of fractures amongst these patients.
A previous study from United Kingdom reported, that GDM increases the risk of fractures, especially hip fractures [5]. To the best of our knowledge, no other study has examined the risk of fractures after GDM. Therefore, the aim of this study was to examine, if the GDM increases the risk of fractures in fertile-aged women using nationwide registers.
Materials and methods
In this retrospective register-based study, data from the National Medical Birth Register (MBR) (1.1.2004–31.12.2013) was combined with data from the Care Register for Health Care (1.1.2004–31.12.2018). Both registers are maintained by the Finnish Institute for Health and Welfare. The MBR contains information on pregnancies, delivery statistics, and the perinatal outcomes, including GDM. We included all pregnancies in women aged 15 to 44 recorded in the MBR between 2004 and 2013 that led to birth. In Finland, GDM is diagnosed in second trimester with 75 g oral glucose test. Data from the Care Register for Health Care contained information on all fractures treated at secondary or tertiary level units between 2004 and 2018. International Classification of Diseases tenth revision (ICD-10) codes were used to identify fracture patients. Fractures of the upper extremity, spine and pelvis, and lower extremity were included in the study. The specific ICD-10 codes with definitions for each fracture included in this study are presented in Appendix 1. The dates of the fracture hospitalization periods found in the Care Register for Health Care were used to compare the risk for a woman sustaining a fracture after giving birth. Based on ICD-10 diagnoses, women with diagnosed type 1 DM were excluded. Forming of the study groups is shown in a flowchart in Appendix 2.
The Cox regression model was used to evaluate the risk for fracture in women with gestational diabetes. Women without gestational diabetes formed the control group. The start point for the follow-up was the date of giving birth. The endpoint of the follow-up was the first fracture hospitalization after giving birth, start of the next pregnancy, or the common endpoint of the follow-up, which was 1–5 years after giving birth, based on the chosen length of the follow-up. The model was created separately with one, two-, three-, four-, and five-year follow-up (each follow-up time starting from the delivery) to analyze the risk with different time periods after the pregnancy, as the length of the changes in physiology after GDM remains unknown. The models with different follow-up times were analyzed separately. The results were interpreted with hazard ratios (HR) and adjusted hazard ratios (aHR) with 95% confidence intervals (CI). Proportional hazards assumption in the cox model was tested using Schoenfeld residuals, and the assumption was not violated. Models were adjusted with body mass index (BMI), age and smoking status of the mother during pregnancy. The adjustments were chosen based on known risk factors for fractures.
Results
A total of 106 146 pregnancies with GDM were included. Of these, 918 (0.86%) women sustained a fracture during the following 5 years after the pregnancy. The control group consisted of 693 338 pregnancies, of which 5494 (0.57%) women sustained a fracture during the following 5 years. Both study groups had similar absolute risk for the fractures after pregnancy throughout the whole 5-year follow-up, the risk increasing up to 0.012 in both groups (Fig. 1).
There was no increased risk for any type of fractures observed among women with GDM. In fact, as the follow-up time lengthened, the risk for fractures was lower among women with GDM. With a 4-year follow-up, the aHR for any fracture for women with GDM was 0.89 (CI 0.82–0.96) and with 5-year follow-up 0.90 (CI 0.83–0.97). Adjusting the models decreased the risk for fractures among women with GMD markedly (Table 1).
Discussion
GDM doesn’t increase the risk for fractures after pregnancy based on our results. One study has previously examined the effects of GDM on subsequent fracture risk. In this study, the risk for all fractures and hip fractures was found to be markedly higher [5]. However, based on our results, the toal risk for any fracture after pregnancy was not higher at any case. In addition, the risk for hip fractures was not higher either. According to our results, adjusting the model with BMI, smoking status, and age of the mother decreased the risk for fractures (especially in lower extremity), which might indicate that these factors are more likely the reason for the increase in the risk for fractures, not the physiologic chances caused by GDM.
The strength of our study is the large nationwide register with a GDM registered for all pregnancies during the study period. Furthermore, GDM screening practice has remained unchanged during our study period. The register data used in our study are routinely collected with structured forms with national instructions, which ensures good coverage (over 99%) and reduces possible reporting and selection bias. The main limitation of our study is the missing clinical information on the fractures included in this study (e.g., radiological finding, trauma mechanisms).
References
Ferrari SL, Abrahamsen B, Napoli N et al (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29(12):2585–2596. https://doi.org/10.1007/s00198-018-4650-2
Cho NH, Shaw JE, Karuranga S et al (2018) IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271–281. https://doi.org/10.1016/j.diabres.2018.02.023
Shah NS, Wang MC, Freaney PM et al (2021) Trends in gestational diabetes at first live birth by race and ethnicity in the US, 2011–2019. JAMA 326(7):660–669. https://doi.org/10.1001/jama.2021.7217
Zhu Y, Zhang C (2016) Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Curr Diab Rep 16(1):7. https://doi.org/10.1007/s11892-015-0699-x
Ahmeidat A, Bhattacharya S, Luben RN, Khaw KT, Myint PK (2021) Long-term effects of gestational diabetes on bone mineral density and fracture risk: analysis of the Norfolk cohort of the European prospective Investigation into Cancer (EPIC-Norfolk) population-based study. Maturitas 144:68–73. https://doi.org/10.1016/j.maturitas.2020.11.005
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest
Ethical approval
In accordance with the instructions of the Finnish regulations, our register-based cohort study did not need ethical approval, and therefore it did not undergo ethical evaluation by the local ethical committee.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article belongs to the topical collection Pregnancy and Diabetes, Managed by Antonio Secchi and Marina Scavini.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Vaajala, M., Liukkonen, R., Kuitunen, I. et al. The effect of gestational diabetes on the fracture risk after pregnancy: a nationwide register-based study. Acta Diabetol 59, 1385–1389 (2022). https://doi.org/10.1007/s00592-022-01907-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-022-01907-x